Company Spotlight – Alamar
“While most liquid biopsy efforts focus on circulating tumor DNA (ctDNA), Alamar is taking a different path, looking for circulating cancer-associated protein biomarkers,” said Nick Naclerio, Ph.D., Founding Partner of Illumina Ventures. “This is mostly undiscovered territory and could ultimately lead to highly sensitive diagnostics that find cancer and other diseases early when they are most ...
Genomeweb: Stilla Technologies Raises €31.3M In Financing
Stilla Technologies announced on Tuesday it has raised €31.3 million ($35.2 million) in new funding. The Paris-based firm will use the funds to expand its global commercial presence and develop its next-generation digital PCR platform.
Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing
Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the completion of an oversubscribed and up-sized $215 million Series B financing. Including this round, the Company has raised over $300 million to date.
DNA Script Raises $165M In Oversubscribed Series C Financing
DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C financing led by Coatue Management and Catalio Capital Management. The new funds will be used to accelerate expansion and commercialization of the company’s revolutionary SYNTAX Platform.